David J. Friedman

13.8k total citations · 3 hit papers
102 papers, 8.2k citations indexed

About

David J. Friedman is a scholar working on Nephrology, Molecular Biology and Genetics. According to data from OpenAlex, David J. Friedman has authored 102 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Nephrology, 31 papers in Molecular Biology and 25 papers in Genetics. Recurrent topics in David J. Friedman's work include Renal Diseases and Glomerulopathies (39 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Chronic Kidney Disease and Diabetes (20 papers). David J. Friedman is often cited by papers focused on Renal Diseases and Glomerulopathies (39 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Chronic Kidney Disease and Diabetes (20 papers). David J. Friedman collaborates with scholars based in United States, Israel and Spain. David J. Friedman's co-authors include Martin R. Pollak, Simon C. Robson, Giulio Genovese, Karen M. Dwyer, Terry B. Strom, Silvia Deaglio, Wenda Gao, Joel Linden, Vijay K. Kuchroo and Anna Erat and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

David J. Friedman

97 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

2007 1.8k citations Silvia Deaglio, Karen M. Dwyer et al. The Journal of Experimental Medicine profile →
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans

2010 1.3k citations Giulio Genovese, David J. Friedman et al. Science profile →
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants

2023 98 citations David J. Friedman, Martin R. Pollak et al. profile →

Peers

Countries citing papers authored by David J. Friedman

Since Specialization

Citations

This map shows the geographic impact of David J. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Friedman more than expected).

Fields of papers citing papers by David J. Friedman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Friedman. The network helps show where David J. Friedman may publish in the future.

Co-authorship network of co-authors of David J. Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Friedman. A scholar is included among the top collaborators of David J. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Friedman. David J. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association between Apolipoprotein L1 genetic variants and risk of preeclampsia and preterm birth among U.S. Black women 2025 ·European Journal of Obstetrics & Gynecology and Reproductive Biology X ·(unknown), David J. Friedman, Chunyu Liu, Kathryn L. Lunetta, Gary Zirpoli, Julie R. Palmer	1
2	Q-switch Tm:YAP laser for dermatology applications 2025 ·(unknown), (unknown), David J. Friedman, Salman Noach	0
3	Evaluation of a Novel Ablative 1940 nm Pulsed Laser for Skin Rejuvenation 2024 ·Lasers in Surgery and Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), David J. Friedman, Salman Noach	3
4	Ethical considerations for genetic research in low-income countries: perceptions of informed consent, data sharing, and expectations in Nicaragua 2023 ·European Journal of Human Genetics ·(unknown), (unknown), (unknown), (unknown), (unknown), Damaris López-Pilarte, (unknown), David J. Friedman, Daniel R. Brooks, Madeleine K. Scammell, Catharine Wang	3
5	Point-of-Care Testing in Chronic Kidney Disease of Non-Traditional Origin: Considerations for Clinical, Epidemiological, and Health Surveillance Research and Practice 2023 ·Annals of Global Health ·Miranda Dally, Juan José Amador, Jaime Butler-Dawson, Damaris López-Pilarte, (unknown), Lyndsay Krisher, (unknown), (unknown), Joseph Kupferman, David J. Friedman, Benjamin R. Griffin, Lee S. Newman, Daniel R. Brooks	2
6	Metabolic Features of Increased Gut Permeability, Inflammation, and Altered Energy Metabolism Distinguish Agricultural Workers at Risk for Mesoamerican Nephropathy 2023 ·Metabolites ·Nathan H. Raines, Dominick Leone, Cristina O’Callaghan‐Gordo, Oriana Ramírez‐Rubio, Juan José Amador, (unknown), Iris Delgado, Jessica H. Leibler, Nieves Embade, Rubén Gil‐Redondo, Chiara Bruzzone, Maider Bizkarguenaga, Madeleine K. Scammell, Samir M. Parikh, Óscar Millet, Daniel R. Brooks, David J. Friedman	7
7	Urinary Metabolomic Profile of Youth at Risk of Chronic Kidney Disease in Nicaragua 2023 ·Kidney360 ·Samantha Hall, Nathan H. Raines, Oriana Ramírez‐Rubio, Juan José Amador, Damaris López-Pilarte, Cristina O’Callaghan‐Gordo, Rubén Gil‐Redondo, Nieves Embade, Óscar Millet, (unknown), (unknown), Sinead A. Keogh, Iris Delgado, David J. Friedman, Daniel R. Brooks, Jessica H. Leibler	3
8	Urinary Metals Concentrations and Biomarkers of Autoimmunity among Navajo and Nicaraguan Men 2020 ·International Journal of Environmental Research and Public Health ·Madeleine K. Scammell, (unknown), Rebecca L. Laws, Robert L. Rubin, Daniel R. Brooks, Juan José Amador, Damaris López-Pilarte, Oriana Ramírez‐Rubio, David J. Friedman, Michael D. McClean, (unknown), Johnnye Lewis, Esther Erdei	17
9	Contributions of Rare Gene Variants to Familial and Sporadic FSGS 2019 ·Journal of the American Society of Nephrology ·Minxian Wang, Justin Chun, Giulio Genovese, (unknown), (unknown), (unknown), David J. Friedman, Gerald B. Appel, Richard P. Lifton, Shrikant Mane, Martin R. Pollak	35
10	Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background 2019 ·Kidney International ·(unknown), Shrijal S. Shah, (unknown), (unknown), Seth L. Alper, Martin R. Pollak, David J. Friedman	40
11	Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1 2014 ·Kidney International ·Brendan Nichols, (unknown), Jessica H. Lee, (unknown), Michael Wilmot, Vivette D. D’Agati, Glen S. Markowitz, Jeffrey B. Kopp, Seth L. Alper, Martin R. Pollak, David J. Friedman	253
12	Increased Burden of Cardiovascular Disease in Carriers of APOL1 Genetic Variants 2013 ·Circulation Research ·Kaoru Ito, Alexander G. Bick, Jason Flannick, David J. Friedman, Giulio Genovese, Michael Parfenov, Steven R. DePalma, Namrata Gupta, Stacey Gabriel, Herman A. Taylor, Ervin R. Fox, Christopher Newton‐Cheh, Sekar Kathiresan, Joel N. Hirschhorn, David Altshuler, Martin R. Pollak, James G. Wilson, Jonathan G. Seidman, Christine E. Seidman	110
13	The APOL1 Genotype of African American Kidney Transplant Recipients Does Not Impact 5-Year Allograft Survival 2012 ·American Journal of Transplantation ·(unknown), Vineeta Kumar, Tom A. Williams, Reza Abdi, Andrea J. Bernhardy, Charissa A. Dyer, S Conte, Giulio Genovese, Michael D. Ross, David J. Friedman, Robert S. Gaston, Edgar L. Milford, Martin R. Pollak, Anil Chandraker	133
14	Genetics of kidney failure and the evolving story of APOL1 2011 ·Journal of Clinical Investigation ·David J. Friedman, Martin R. Pollak	94
15	Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans breakdown → 2010 ·Science ·Giulio Genovese, David J. Friedman, Michael D. Ross, Laurence Lecordier, Pierrick Uzureau, Barry I. Freedman, Donald W. Bowden, Carl D. Langefeld, Tarás K. Oleksyk, (unknown), Andrea J. Bernhardy, Andrew A. Hicks, George W. Nelson, Benoît Vanhollebeke, Cheryl A. Winkler, Jeffrey B. Kopp, Etienne Pays, Martin R. Pollak	1329
16	Leveraging Technologies: DIGE and MudPIT. 2010 ·Journal of Biomolecular Techniques JBT ·W. Hayes McDonald, David J. Friedman	1
17	CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease 2009 ·Proceedings of the National Academy of Sciences ·David J. Friedman, Beat Künzli, Yousif I. A-Rahim, Jean Sévigny, Pascal O. Berberat, Keiichi Enjyoji, Eva Csizmadia, Helmut Frieß, Simon C. Robson	230
18	The Use of Hybrid Radiofrequency Device for the Treatment of Rhytides and Lax Skin 2007 ·Dermatologic Surgery ·David J. Friedman, Leon Gilead	38
19	Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression breakdown → 2007 ·The Journal of Experimental Medicine ·Silvia Deaglio, Karen M. Dwyer, Wenda Gao, David J. Friedman, Anny Usheva, Anna Erat, Jiang‐Fan Chen, (unknown), Joel Linden, Mohamed Oukka, Vijay K. Kuchroo, Terry B. Strom, Simon C. Robson	1837
20	Functional Comparison of Mouse slc26a6 Anion Exchanger with Human SLC26A6 Polypeptide Variants 2004 ·Journal of Biological Chemistry ·Marina N. Chernova, Lianwei Jiang, David J. Friedman, Rachel Darman, Hannes Lohi, Juha Kere, David H. Vandorpe, Seth L. Alper	122

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact